| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Allen D Roses | |
| P2860 | cites work | Prospects for whole-genome linkage disequilibrium mapping of common disease genes | Q77883184 |
| Pharmacogenomic-guided drug development: regulatory perspective | Q78045528 | ||
| Genetic variations in HLA-B region and hypersensitivity reactions to abacavir | Q28214097 | ||
| An SNP map of the human genome generated by reduced representation shotgun sequencing | Q30940258 | ||
| An SNP map of human chromosome 22. | Q30940265 | ||
| Pharmacogenetics and the practice of medicine | Q33906823 | ||
| SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease | Q33907034 | ||
| A SNPshot: pharmacogenetics and the future of drug therapy | Q33971641 | ||
| Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. | Q34115785 | ||
| Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir | Q34117815 | ||
| Pharmacogenetics place in modern medical science and practice | Q34564361 | ||
| Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine. | Q38294179 | ||
| A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team | Q43514238 | ||
| Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial | Q47247699 | ||
| Genetic linkage studies in Alzheimer's disease families. | Q53191751 | ||
| Analysis of association at single nucleotide polymorphisms in the APOE region. | Q53232876 | ||
| Genome research: map of the human genome 3.0. | Q53478413 | ||
| Role of Drug Disposition in Drug Hypersensitivity: A Chemical, Molecular, and Clinical Perspective | Q57302806 | ||
| Idiosyncratic reactions to drugs: can medicine response profiles provide a dynamic drug surveillance system? | Q73245636 | ||
| The human medicine project has started: place your bets now | Q73637627 | ||
| Human genome research. SNP mappers confront reality and find it daunting | Q73650209 | ||
| Genetics. Can SNPs deliver on susceptibility genes? | Q74268722 | ||
| Testing drug response in the presence of genetic information: sampling issues for clinical trials | Q74278928 | ||
| Pharmacogenetics | Q74843888 | ||
| A 4-Mb high-density single nucleotide polymorphism-based map around human APOE | Q77526623 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 277-283 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | The Pharmacogenomics Journal | Q10534704 |
| P1476 | title | SNPs--where's the beef? | |
| P478 | volume | 2 |
| Q44796890 | Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations |
| Q36039820 | Disease-specific target selection: a critical first step down the right road |
| Q80044051 | Pharmacogenomics in drug development: societal and technical aspects |
Search more.